DMYD B — Diamyd Medical AB Balance Sheet
0.000.00%
Last trade - 00:00
- SEK1.03bn
- SEK920.03m
- SEK0.55m
2019 August 31st | 2020 August 31st | 2021 August 31st | 2022 August 31st | 2023 August 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | SAS | SAS | SAS | SAS | SAS |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 56.7 | 68.4 | 139 | 160 | 128 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 1.43 | 3.67 | 1.65 | 2.44 | 4.67 |
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 61.9 | 72.4 | 163 | 173 | 141 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | — | 1.97 | 5.55 | 45.7 | 52.3 |
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 74.2 | 89.8 | 201 | 237 | 206 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 10.6 | 16.5 | 11.4 | 21.4 | 19.9 |
Long Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 11.4 | 17.3 | 12.2 | 22.1 | 36.4 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | 62.8 | 72.5 | 189 | 214 | 169 |
Total Liabilities & Shareholders' Equity | 74.2 | 89.8 | 201 | 237 | 206 |
Total Common Shares Outstanding |